Q-Line Biotech Ltd Analysis Subscription Profit & Loss Ratios Objects Dates Lot Size Allotment

Q-Line Biotech Ltd

·
₹343.00 Issue Price
2026-05-21 – 2026-05-25
qlinebiotech.com Mainboard · NSE SME
Open Date
2026-05-21
Close Date
2026-05-25
Listing Date
2026-05-25
Allotment Date
2026-05-26
Current Price
₹343.00
High / Low
₹— / ₹—
ROCE
13.32 %
ROE
16.88 %
Face Value
₹10
Add ratio to table Edit ratios
About
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing,…
📍 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station Luc…
📞 +91 522-2435570
✉️ compliance@qlinebiotech.com

Analysis

Pros

  • ROE of 16.88%% indicates good return on equity.
  • ROCE of 13.32%% shows efficient capital usage.
  • PAT margin of 16.65%%.

Cons

  • Debt/equity of 1.06x may be high.

Pros and cons are machine generated. Please exercise caution and do your own analysis.

Subscription Status

Consolidated figures
Day 1
0.00×
Day 2
0.00×
Day 3
0.00×
MetricQIBNII (HNI)RetailTotal
Subscription — — — —
Shares 29,69,200 8,91,600 20,79,200 62,53,200
Bids — — — —
▼ Category-wise Detailed Breakdown
CategorySubscriptionOffered Bid SharesAmt (₹ Cr)
QIB - 29,69,200 — ₹101.84
NII (HNI) - 8,91,600 — ₹30.58
Retail - 20,79,200 — ₹71.32
Market Maker 1.00×
3,13,200 3,13,200 ₹10.74
Total - 62,53,200 3,13,200 ₹214.48 Cr
Applications: - Total Bid Amount: ₹214.48 Cr

Profit & Loss

Figures in ₹ Crores / Amount in ₹ Crore
Metric 31 Dec 202531 Mar 202531 Mar 2024
Revenue 236.50 322.58 206.45
EBITDA 64.23 71.32 37.63
Profit After Tax 38.69 28.13 34.44
Net Worth -0.04 189.95 161.81
Total Assets 561.34 455.49 339.25
Reserves 21,288,920.00 188.37 160.24
Borrowings 243.85 164.95 96.91
Sales Growth
3 Years:-12.7%
Latest:206.45 Cr
Profit Growth
3 Years:-11%
Latest PAT:34.44 Cr
Return on Equity
ROE:16.88%%
ROCE:13.32%%

Key Financial Ratios

Profitability
ROE 16.88%%
ROCE 13.32%%
RONW 16.88%%
PAT Margin 16.65%%
EBITDA Margin 27.64%%
Valuation
Leverage & Growth
Debt / Equity 1.06×
Sales Growth (3yr) -12.7%
Profit Growth (3yr) -11%
Latest Revenue 206.45 Cr
Latest PAT 34.44 Cr

Objects of the Issue

1 To meet working capital requirements ₹93.50 Cr
2 Repayment of certain borrowing availed by the Company, in part or full ₹90.00 Cr
3 General Corporate Purposes

IPO Schedule & Important Dates

IPO Open
2026-05-21
Upcoming
IPO Close
2026-05-25
Upcoming
Allotment
2026-05-26
Upcoming
Refund
2026-05-27
Upcoming
Demat Credit
2026-05-27
Upcoming
Listing
2026-05-25
Upcoming

Lot Size & Investment Details

RETAIL MIN
₹137,200
1 lot · 400 shares
RETAIL MAX
₹274,400
2 lots · 800 shares
HNI MIN
₹411,600
3 lots
Category Lots Shares Amount (₹)
Retail (Min) 400 400 ₹137,200
Retail (Max) 2 800 ₹274,400
HNI (Min) 3 1200 ₹411,600
Pre-Issue Holding: 1,70,74,999 shares Post-Issue Holding: 2,33,28,199 shares

Lead Managers & Market Makers

Book Running Lead Managers
Hem Securities Ltd Share India Capital Services Pvt.Ltd
Market Makers
Hem Finlease Pvt.Ltd

Allotment Status

Allotment Date: 2026-05-26
Registrar: Purva Sharegistry (India) Pvt.Ltd
Check Allotment
+91-022-23018261/ 23016761
support@purvashare.com
https://www.purvashare.com/investor-service/ipo-query